fNPC-GDNF transplants in the ALS rat motor cortex delayed disease onset and extended lifespan (Thomsen et al., 2018), providing the basis for our current clinical trial delivering CNS10-NPC-GDNF to the motor cortex of ALS patients. This evidence concerns the gene GDNF and amyotrophic lateral sclerosis.